Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diffuse Large B-Cell Lymphoma
|
127 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.030 | 1.000 | 3 | 2010 | 2015 | |||||
Adult Diffuse Large B-Cell Lymphoma
|
46 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.020 | 1.000 | 2 | 2010 | 2013 | |||||
Bronchiolitis
|
32 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Lymphoma, Non-Hodgkin
|
197 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.020 | 1.000 | 2 | 2007 | 2009 | |||||
Adult Hodgkin Lymphoma
|
27 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Adult Lymphoma
|
66 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Childhood Hodgkin Lymphoma
|
29 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Childhood Lymphoma
|
66 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
|
14 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Classical Hodgkin's Lymphoma
|
20 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Colorectal Carcinoma
|
1962 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Hodgkin Disease
|
148 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Lymphoma
|
91 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Lymphoma, Non-Hodgkin, Familial
|
79 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
9 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Malignant neoplasm of prostate
|
1082 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Malignant Neoplasms
|
1641 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Mantle cell lymphoma
|
19 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Primary malignant neoplasm
|
1374 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Prostate carcinoma
|
1168 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Rheumatoid Arthritis
|
2387 | 0.658 | 0.400 | 1 | 206776020 | intron variant | A/T | snv | 0.32 | 0.010 | 1.000 | 1 | 2018 | 2018 |